Studies	NNS
of	IN
hepatocyte-growth-factor	NN
in	IN
bronchoalveolar	JJ
lavage	NN
fluid	NN
in	IN
chronic	JJ
interstitial	JJ
lung	NN
diseases	NNS
.	.

INTRODUCTION	NN
:	:
Previous	JJ
studies	NNS
have	VBP
suggested	VBN
that	IN
hepatocyte-growth-factor	NN
(	(
HGF	NN
)	)
inhibits	VBZ
lung	NN
fibrosis	NN
as	IN
an	DT
antagonist	NN
of	IN
transforming-growth-factor-b	NN
(	(
TGF	NN
-	:
b	LS
)	)
.	.

OBJECTIVES	NNS
:	:
We	PRP
assessed	VBD
HGF	NN
expression	NN
levels	NNS
in	IN
the	DT
lower	JJR
airways	NNS
of	IN
patients	NNS
with	IN
selected	VBN
interstitial	JJ
lung	NN
diseases	NNS
.	.

PATIENTS	NNS
AND	CC
METHODS	NNS
:	:
HGF	NN
levels	NNS
were	VBD
examined	VBN
by	IN
an	DT
enzyme	NN
-	:
linked	JJ
immunosorbent	JJ
assay	NN
in	IN
bronchoalveolar	JJ
lavage	NN
(	(
BAL	NN
)	)
fluid	NN
supernatants	NNS
from	IN
patients	NNS
with	IN
pulmonary	JJ
sarcoidosis	NN
(	(
PS	NNP
,	,
n	NN
=	JJ
52	CD
)	)
,	,
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
,	,
n	NN
=	JJ
23	CD
)	)
,	,
nonspecific	JJ
interstitial	JJ
pneumonia	NN
(	(
NSIP	NN
,	,
n	NN
=	JJ
14	CD
)	)
,	,
extrinsic	JJ
allergic	JJ
alveolitis	NN
(	(
EAA	NN
,	,
n	NN
=	JJ
6	CD
)	)
,	,
bronchiolitis	NN
obliterans	NNS
organizing	VBG
pneumonia	NN
(	(
BOOP	NN
,	,
n	NN
=	JJ
8	CD
)	)
,	,
chronic	JJ
eosinophilic	JJ
pneumonia	NN
(	(
EP	NN
,	,
n	NN
=	JJ
6	CD
)	)
,	,
and	CC
in	IN
control	JJ
subjects	NNS
(	(
n	NN
=	JJ
13	CD
)	)
.	.

Intracellular	JJ
HGF	NN
expression	NN
in	IN
BAL	NN
cells	NNS
was	VBD
evaluated	VBN
by	IN
flow	NN
cytometry	NN
.	.

RESULTS	NNS
:	:
HGF	NN
concentrations	NNS
were	VBD
elevated	JJ
in	IN
BAL	NN
fluid	NN
from	IN
nonsmokers	NNS
with	IN
IPF	NN
(	(
261	CD
204	CD
pg/ml	NN
,	,
P	NN
<	JJR
0.02	CD
)	)
,	,
smokers	NNS
with	IN
IPF	NN
(	(
220	CD
13	CD
pg/ml	NN
,	,
P	NN
<	JJR
0.001	CD
)	)
,	,
and	CC
smokers	NNS
with	IN
PS	NNP
(	(
172	CD
33	CD
pg/ml	NN
,	,
P	NN
<	JJR
0.02	CD
)	)
,	,
as	IN
compared	VBN
with	IN
controls	NNS
(	(
148	CD
17	CD
pg/ml	NN
for	IN
nonsmokers	NNS
;	:
137	CD
9	CD
pg/ml	NN
for	IN
smokers	NNS
)	)
.	.

HGF	NN
levels	NNS
were	VBD
positively	RB
correlated	VBN
with	IN
TGF	NN
-	:
b	NN
concentrations	NNS
in	IN
BAL	NN
fluid	NN
(	(
r	NN
=	JJ
0.3	CD
;	:
P	NN
=	JJ
0.02	CD
)	)
and	CC
negatively-with	JJ
vital	JJ
capacity	NN
(	(
r	NN
=	JJ
-0.2	CD
;	:
P	NN
=	JJ
0.02	CD
)	)
.	.

BAL	NN
neutrophils	NNS
,	,
and	CC
,	,
for	IN
the	DT
first	JJ
time	NN
,	,
BAL	NN
lymphocytes	NNS
,	,
were	VBD
identified	VBN
as	IN
intracellular	JJ
HGF	NN
-	:
positive	JJ
cells	NNS
.	.

CONCLUSIONS	NNS
:	:
Our	PRP$
results	NNS
do	VBP
not	RB
support	VB
evidence	NN
for	IN
strong	JJ
antifibrotic	JJ
HGF	NN
activity	NN
.	.

The	DT
highest	JJS
HGF	NN
concentrations	NNS
were	VBD
observed	VBN
in	IN
BAL	NN
fluid	NN
from	IN
patients	NNS
with	IN
IPF	NN
,	,
and	CC
they	PRP
were	VBD
also	RB
positively	RB
correlated	VBN
with	IN
TGF	NN
-	:
b	NN
levels	NNS
.	.

Thus	RB
,	,
although	IN
the	DT
local	JJ
protective	JJ
mechanisms	NNS
such	JJ
as	IN
the	DT
HGF	NN
expression	NN
are	VBP
upregulated	VBN
in	IN
chronic	JJ
interstitial	JJ
lung	NN
diseases	NNS
,	,
they	PRP
are	VBP
not	RB
enough	RB
to	TO
prevent	VB
lung	NN
fibrosis	NN
.	.

